Clinical Trial Update: BTZ-043 Dose Evaluation in Combination and Selection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BTZ-043 dose in combination therapy for pulmonary tuberculosis and other specified pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• BTZ-043 (BTZ-043)

Snippet

Sponsor: Michael Hoelscher | Conditions: Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis | Phase 2 | Status: UNKNOWN